MATERIALS AND METHODS
Tissue culture. The nephrogenic zone of the kidney was prepared from neonatal rabbits. The explants were cultured for 13 days under continuous medium flow (flow rate: 1 ml/h) in a perfusion culture container (Minuth et al., 1992; Minucell and Minutissue, Bad Abbach, Germany) . As basal culture medium IMDM (Gibco BRL-Life Technologies, Eggenstein, Germany) supplemented with 0.1% bovine serum albumin (BSA, Biomol, Hamburg, Germany) was used.
To stimulate renal development, basic culture medium was supplemented with hormones or differentiation factors. Recombinant human GDNF (Prepro Tech Inc., UK) and rat GDNF (Suter-Crazzolara and Unsicker 1995) were applied at a concentration of 5 ng/ml for 13 days of perfusion culture. In another set of experiments explants were stimulated for 1 and 2 days with different hormones. Aldosterone (1 ϫ 10 M, Sigma, Deisenhofen, Germany) and 1.25-dihydroxyvitamin D 3 (1 ϫ 10 Ϫ9 M, Sigma) were applied in combination during the whole culture period. Retinoic acid (3.3 ϫ 10 Ϫ7 M, Sigma, dissolved in ethanol) was applied for 3 h prior to 1 and 2 days of perfusion culture. Control experiments were performed with basal medium alone. All culture experiments were carried out at least in triplicate.
Immunohistochemistry. Vessel development in cultured renal cortex explants was monitored by immunohistochemical methods. Cryosections (8 m) were fixed and incubated with the endothelium specific antibody EC1 as described in detail previously (Kloth et al., 1995) .
RT-PCR analysis. Expression levels of GDNF were studied with a quantitative RT-PCR approach. A detailed description was published recently (SuterCrazzolara and Unsicker, 1996) . PCR products were separated by gel electrophoresis and analyzed by Southern hybridization. Signal intensities were analyzed with a Molecular Dynamics PhosphoImager. The signal intensity of the endogenous GDNF mRNA signal was determined and divided by that of the competitor internal standard RNA (IS-RNA).
RESULTS AND DISCUSSION

GDNF Stimulates Renal Blood Vessel Development
To analyze mechanisms by which GDNF may act during renal blood vessel development, the factor was applied to explants of the nephrogenic zone. To exclude effects of other growth factors present at varying concentrations in serum, a well-established serum-free culture model was employed. This model allows for long-term analysis of effects of growth factors on renal blood vessel development in an organ-specific context (Minuth et al., 1992; Kloth et al., 1995 Kloth et al., , 1998 .
Thin blood vessels can be observed within the nephrogenic zone of the developing kidney (Kloth et al., 1997) . Characteristically, these vessels have lengths of 80 to 100 m and run in a parallel fashion toward the organ capsule (Fig. 1a) . In explants cultured for 13 days in serum-free basal medium, such blood vessels were not detected (Fig. 1b) . These explants reveal clusters of EC1-immunoreactive endothelial cells, not found in the developing kidney or under culturing conditions in the presence of hormones (Kloth et al., 1995) . This indicates that serum-free medium lacks important regulatory signals, which are present in situ.
In contrast, explants cultured for 13 days in the presence of GDNF contain vessels that retained integrity and their typical spatial architecture. Following application of GDNF the vessels have broadened and elongated (Fig. 1c) . Moreover, cultured explants have widened, and vessel-like structures of about 150 m length are detected frequently. The mitogenic effect of GDNF was confirmed by comparing the amount of proliferating cells in GDNF-stimulated and control explants (data not shown). Addition of GDNF results in an enlarged vessel network which maintains its typical spatial organization even after 13 days of culture. GDNF therefore appears to mediate both mitogenic as well as morphogenic effects on the developing vessels. The factor stimulates vessel elongation within a regular framework, and the vessels retain their characteristic three-dimensional organization. These structures are strongly reminiscent of those found in the developing kidney in situ (Fig. 1a) . Furthermore, small capillary-like, lumen-containing structures are a typical feature of GDNF-treated explants (Fig. 1e ), but were never observed in explants cultured in basal medium alone.
GDNF mRNA Levels Are Not Significantly Altered by Stimulation of Cortex Explants with Hormones
In the past we have described several hormones that appear to have similar effects on vessel development as those described here for GDNF. These are aldosterone in combination with vitamin D 3 and retinoic acid (Kloth et al., 1995 (Kloth et al., , 1998 . Therefore, we wanted to investigate whether GDNF may act as a mediator for these substances in this process. For this purpose, we have chosen a competitive RT-PCR approach that we have described in detail previously (Suter-Crazzolara and Unsicker, 1996) . GDNF mRNA can be detected in rabbit tissues with oligonucleotides specific for human and rat GDNF (Fig. 2, lanes 1 to 8) . The L-and S-GDNF forms result from an alternative splicing event within GDNF coding sequence (Suter-Crazzolara and Unsicker, 1994). GDNF mRNA can be detected both in explants of the nephrogenic zone (Fig. 2b, lane 1) as well as in the rabbit kidney cortex (data not shown).
Next, cortex explants were analyzed for GDNF mRNA expression levels after either aldosterone in combination with vitamin D 3 or retinoic acid treatment. None of the treatments resulted in an alteration of expression levels of GDNF mRNA. No significant differences in expression levels of GDNF mRNA can be observed between freshly prepared explants (Fig.  2b, lane 1) , explants cultured in basal medium (lane 2), vehicle-treated explants (lanes 5 and 6), or medium supplemented with hormones (lanes 3, 4, 7, and 8). These results indicate that GDNF does not act as a mediator for either of these substances.
Our data do not allow an assessment whether the effects of GDNF are direct or indirect. However, no reports exist to date describing the presence of one of the known GDNF receptors on endothelial cells, which appears to suggest an indirect effect. The expression of the mRNAs for GDNF and its receptors by different cell population of the nephronic zone was demonstrated. While GDNF is produced by the mes- enchymal cells (Hellmich et al., 1996; Suvanto et al., 1996) , the Ret receptor was detected on the epithelium of the uretric bud and the collecting duct ampullae (Pachnis et al., 1993; Schuchardt et al., 1996) . GDNF appears to be an early acting factor essential for kidney development (reviewed by Sariola and Sainio, 1997) .
It may well be that GDNF and the hormones used in this study employ independent pathways to modulate renal vascularization. On the other hand, the investigations of transgenic animals clearly document the superior importance of GDNF for renal development. Thus, we tend to speculate that GDNF is a higher order signal for modulating renal vascularization. The results of our tissue culture experiments carried out in an organotypic context provide first evidence that GDNF may be one of the factors responsible for the coordinated development of collecting ducts, nephrons, and blood vessels in the nephrogenic zone. It would be of main interest to investigate whether GDNF affects the expression of angiogenic factors such as VEGF or hormone receptors by the developing collecting ducts and nephrons.
